Kapoor, P., Gertz, M., Dizona, P., Muchtar, E., Buadi, F., Gonsalves, W., Hobbs, M., Fonder, A., Hwa, Y., Kourelis, T., Dingli, D., Dispenzieri, A., Cook, J., Hayman, S., Binder, M., Abdallah, N., Siddiqui, M., Warsame, R., Rajkumar, S. V., Knopf, B., Kumar, S. (2025). The SCOPE trial: A phase 2 Study of selinexor in combination with pomalidomide and dexamethasone for patients with relapsed and/or refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2281